FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3172699374> ?p ?o ?g. }

• W3172699374 abstract "More than 50% of the world population is chronically infected with herpesviruses. Herpes simplex virus (HSV) infections are the cause of herpes labialis (cold sores), genital herpes, and sight-impairing keratitis. Less frequently, life-threatening disseminated disease (encephalitis and generalized viremia) can also occur, mainly in immunocompromised patients and newborns. After primary infection, HSV persists for life in a latent state in trigeminal or sacral ganglia and, triggered by diverse stimuli, disease recurs in more than 30% of patients up to several times a year. Current therapy with nucleoside analogs targeting the viral polymerase is somewhat effective but limited by poor exposure in the nervous system, and latent infections are not affected by therapy. Here, we report on an inhibitor of HSV helicase-primase with potent in vitro anti-herpes activity, a different mechanism of action, a low frequency of HSV resistance, and a favorable pharmacokinetic and safety profile. Improved target tissue exposure results in superior efficacy in preventing and treating HSV infection and disease in animal models as compared to standard of care. Therapy of primary HSV infections with drug candidate IM-250 {(S)-2-(2',5'-difluoro-[1,1'-biphenyl]-4-yl)-N-methyl-N-(4-methyl-5-(S-methylsulfon-imidoyl)thiazol-2-yl)acetamide} not only reduces the duration of disease symptoms or time to healing but also prevents recurrent disease in guinea pigs. Treatment of recurrent infections reduces the frequency of recurrences and viral shedding, and, unlike nucleosidic drugs, IM-250 remains effective for a time after cessation of treatment. Hence, IM-250 has advantages over standard-of-care therapies and represents a promising therapeutic for chronic HSV infection, including nucleoside-resistant HSV." @default.
• W3172699374 created "2021-06-22" @default.
• W3172699374 creator A5011811987 @default.
• W3172699374 creator A5013972886 @default.
• W3172699374 creator A5028713120 @default.
• W3172699374 creator A5035703144 @default.
• W3172699374 creator A5035991850 @default.
• W3172699374 creator A5038087675 @default.
• W3172699374 creator A5057787747 @default.
• W3172699374 creator A5071290991 @default.
• W3172699374 creator A5071329817 @default.
• W3172699374 creator A5077188358 @default.
• W3172699374 creator A5090332369 @default.
• W3172699374 creator A5090825736 @default.
• W3172699374 date "2021-06-16" @default.
• W3172699374 modified "2023-09-30" @default.
• W3172699374 title "A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections" @default.
• W3172699374 cites W1970142451 @default.
• W3172699374 cites W1988137843 @default.
• W3172699374 cites W2009979602 @default.
• W3172699374 cites W2016176668 @default.
• W3172699374 cites W2019405166 @default.
• W3172699374 cites W2028083264 @default.
• W3172699374 cites W2046801142 @default.
• W3172699374 cites W2064921473 @default.
• W3172699374 cites W2081007549 @default.
• W3172699374 cites W2083083619 @default.
• W3172699374 cites W2090371582 @default.
• W3172699374 cites W2110002916 @default.
• W3172699374 cites W2148365504 @default.
• W3172699374 cites W2153811732 @default.
• W3172699374 cites W2154119901 @default.
• W3172699374 cites W2165683912 @default.
• W3172699374 cites W2336900894 @default.
• W3172699374 cites W2410066853 @default.
• W3172699374 cites W2429897652 @default.
• W3172699374 cites W2540663276 @default.
• W3172699374 cites W2562795102 @default.
• W3172699374 cites W2590477501 @default.
• W3172699374 cites W2593992901 @default.
• W3172699374 cites W2724844135 @default.
• W3172699374 cites W2892388654 @default.
• W3172699374 cites W2899477426 @default.
• W3172699374 cites W2910730332 @default.
• W3172699374 cites W2940292178 @default.
• W3172699374 cites W2947856848 @default.
• W3172699374 cites W2953732145 @default.
• W3172699374 cites W3004523814 @default.
• W3172699374 cites W3009248191 @default.
• W3172699374 cites W3021230020 @default.
• W3172699374 cites W3035471904 @default.
• W3172699374 cites W86358223 @default.
• W3172699374 doi "https://doi.org/10.1126/scitranslmed.abf8668" @default.
• W3172699374 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34135112" @default.
• W3172699374 hasPublicationYear "2021" @default.
• W3172699374 type Work @default.
• W3172699374 sameAs 3172699374 @default.
• W3172699374 citedByCount "17" @default.
• W3172699374 countsByYear W31726993742021 @default.
• W3172699374 countsByYear W31726993742022 @default.
• W3172699374 countsByYear W31726993742023 @default.
• W3172699374 crossrefType "journal-article" @default.
• W3172699374 hasAuthorship W3172699374A5011811987 @default.
• W3172699374 hasAuthorship W3172699374A5013972886 @default.
• W3172699374 hasAuthorship W3172699374A5028713120 @default.
• W3172699374 hasAuthorship W3172699374A5035703144 @default.
• W3172699374 hasAuthorship W3172699374A5035991850 @default.
• W3172699374 hasAuthorship W3172699374A5038087675 @default.
• W3172699374 hasAuthorship W3172699374A5057787747 @default.
• W3172699374 hasAuthorship W3172699374A5071290991 @default.
• W3172699374 hasAuthorship W3172699374A5071329817 @default.
• W3172699374 hasAuthorship W3172699374A5077188358 @default.
• W3172699374 hasAuthorship W3172699374A5090332369 @default.
• W3172699374 hasAuthorship W3172699374A5090825736 @default.
• W3172699374 hasConcept C12914427 @default.
• W3172699374 hasConcept C159047783 @default.
• W3172699374 hasConcept C203014093 @default.
• W3172699374 hasConcept C2522874641 @default.
• W3172699374 hasConcept C2776159415 @default.
• W3172699374 hasConcept C2776185481 @default.
• W3172699374 hasConcept C2776543447 @default.
• W3172699374 hasConcept C2777333352 @default.
• W3172699374 hasConcept C2777965375 @default.
• W3172699374 hasConcept C2779820661 @default.
• W3172699374 hasConcept C2781196997 @default.
• W3172699374 hasConcept C2908647359 @default.
• W3172699374 hasConcept C55493867 @default.
• W3172699374 hasConcept C71924100 @default.
• W3172699374 hasConcept C86803240 @default.
• W3172699374 hasConcept C99454951 @default.
• W3172699374 hasConceptScore W3172699374C12914427 @default.
• W3172699374 hasConceptScore W3172699374C159047783 @default.
• W3172699374 hasConceptScore W3172699374C203014093 @default.
• W3172699374 hasConceptScore W3172699374C2522874641 @default.
• W3172699374 hasConceptScore W3172699374C2776159415 @default.
• W3172699374 hasConceptScore W3172699374C2776185481 @default.
• W3172699374 hasConceptScore W3172699374C2776543447 @default.
• W3172699374 hasConceptScore W3172699374C2777333352 @default.
• W3172699374 hasConceptScore W3172699374C2777965375 @default.
• W3172699374 hasConceptScore W3172699374C2779820661 @default.

• next